Kidney International Reports

Article	Citations
COVID-19 Vaccination and Glomerulonephritis	139
Chronic Inflammation in Chronic Kidney Disease Progression: Role of Nrf2	131
De Novo ANCA-Associated Vasculitis With Glomerulonephritis in COVID-19	112
Safety, Tolerability and Efficacy of Narsoplimab, a Novel MASP-2 Inhibitor for the Treatment of IgA Nephropathy	98
A Systematic Review of Immune Checkpoint Inhibitor–Associated Glomerular Disease	95
Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients With CKD	95
Prescribing SGLT2 Inhibitors in Patients With CKD: Expanding Indications and Practical Considerations	90
Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or Without Sodium-Glucose Cotransporter-2 Inhibitor Therapy	80
Safety of Remdesivir in Patients With Acute Kidney Injury or CKD	76
Roxadustat for CKD-related Anemia in Non-dialysis Patients	73
Biomarkers, Clinical Features, and Rechallenge for Immune Checkpoint Inhibitor Renal Immune-Related Adverse Events	67
A Systematic Review of COVID-19 and Kidney Transplantation	65
A Randomized Trial of Roxadustat in Anemia of Kidney Failure: SIERRAS Study	64
Complement in Secondary Thrombotic Microangiopathy	63
IgA Vasculitis With Nephritis (Henoch−Schönlein Purpura) in a COVID-19 Patient	63
Use of Remdesivir in Patients With COVID-19 on Hemodialysis: A Study of Safety and Tolerance	61
Systematic Review of Safety and Efficacy of COVID-19 Vaccines in Patients With Kidney Disease	58
Survey of US Living Kidney Donation and Transplantation Practices in the COVID-19 Era	52
Phase 2 Study of the Factor XI Antisense Inhibitor IONIS-FXIRx in Patients With ESRD	49
Dialysis-Induced Cardiovascular and Multiorgan Morbidity	49
Surgical Management of Secondary Hyperparathyroidism	48
Randomized Phase II JANUS Study of Atacicept in Patients With IgA Nephropathy and Persistent Proteinuria	48
Decreasing Incidence of Acute Kidney Injury in Patients with COVID-19 Critical Illness in New York City	48
Uric Acid and Chronic Kidney Disease: Still More to Do	47
Antineutrophil Cytoplasmic Autoantibody–Associated Glomerulonephritis Following the Pfizer-BioNTech COVID-19 Vaccine	46

Rituximab in Membranous Nephropathy	45
Randomized Phase 2 Trial of Telitacicept in Patients With IgA Nephropathy With Persistent Proteinuria	43
Frailty in CKD and Transplantation	43
Transplantation for Primary Hyperoxaluria Type 1: Designing New Strategies in the Era of Promising Therapeutic Perspectives	41
The Kidney Protective Effects of the Sodium–Glucose Cotransporter-2 Inhibitor, Dapagliflozin, Are Present in Patients With CKD Treated With Mineralocorticoid Receptor Antagonists	39
Postvaccine Anti–SARS-CoV-2 Spike Protein Antibody Development in Kidney Transplant Recipients	38
Phase 3 Study of Roxadustat to Treat Anemia in Non–Dialysis-Dependant CKD	38
Attitudes and Practices of Australian Nephrologists Toward Implementation of Clinical Genomics	37
Toxic Nephropathy Secondary to Chronic Mercury Poisoning: Clinical Characteristics and Outcomes	37
Mineralocorticoid Receptor Antagonism in Chronic Kidney Disease	36
Adherence to the Kidney Disease: Improving Global Outcomes CKD Guideline in Nephrology Practice Across Countries	36
Determinants of the Evolution of Kidney Function With Age	35
Low Serum Potassium Levels and Clinical Outcomes in Peritoneal Dialysis—International Results from PDOPPS	35
Long-Term Efficacy and Safety of the Long-Acting Complement C5 Inhibitor Ravulizumab for the Treatment of Atypical Hemolytic Uremic Syndrome in Adults	34
Phosphate Balance and CKD–Mineral Bone Disease	32
Convolutional Neural Network Model for Intensive Care Unit Acute Kidney Injury Prediction	32
The Crystalline Nephropathies	32
Evaluation of Changes Over Time in the Drug Burden and Medication Regimen Complexity in ESRD Patients Before and After Renal Transplantation	32
Alternative Complement Pathway Inhibition With Iptacopan for the Treatment of C3 Glomerulopathy-Study Design of the APPEAR-C3G Trial	31
Urine Single-Cell RNA Sequencing in Focal Segmental Glomerulosclerosis Reveals Inflammatory Signatures	31
Molidustat for Japanese Patients With Renal Anemia Receiving Dialysis	30
A Systematic Study of the Prevalence and Risk Factors of CKD in Uddanam, India	30
Systematic Review and Meta-analysis of COVID-19 and Kidney Transplant Recipients, the South West London Kidney Transplant Network Experience	30
Sarcopenia and Frailty: Challenges in Mainstream Nephrology Practice	29
Health-Related Quality of Life in People Across the Spectrum of CKD	29
Study Design: Human Leukocyte Antigen Class I Molecule A∗02-Chimeric Antigen Receptor Regulatory T Cells in Renal Transplantation	29
High Blood Pressure in Children and Adolescents: Current Perspectives and Strategies to Improve Future Kidney and Cardiovascular Health	29
Central Venous Catheters for Hemodialysis—the Myth and the Evidence	29
RETRACTED: Pooled Analysis of Roxadustat for Anemia in Patients With Kidney Failure Incident to Dialysis	29
Clinical Efficacy of SARS-CoV-2 Vaccination in Hemodialysis Patients	28
Mitochondrial Disease and the Kidney With a Special Focus on CoQ10 Deficiency	28
A Phase 3 Study of Enarodustat in Anemic Patients with CKD not Requiring Dialysis: The SYMPHONY ND Study	28
Markers of Kidney Injury, Inflammation, and Fibrosis Associated With Ertugliflozin in Patients With CKD and Diabetes	28
Nephrologists’ Perspectives on Gender Disparities in CKD and Dialysis	28
Use and Safety of Remdesivir in Kidney Transplant Recipients With COVID-19	28
Evaluation of Clazakizumab (Anti–Interleukin-6) in Patients With Treatment-Resistant Chronic Active Antibody-Mediated Rejection of Kidney Allografts	28
Compassionate Use of Avacopan in Difficult-to-Treat Antineutrophil Cytoplasmic Antibody–Associated Vasculitis	27
Deceased Donor Kidneys Utilization and Discard Rates During COVID-19 Pandemic in the United States	27
A Multicenter Randomized Clinical Trial of Hemodialysis Access Blood Flow Surveillance Compared to Standard of Care: The Hemodialysis Access Surveillance Evaluation (HASE) Study	27
Renal Function Decline Under Therapy With Small Interfering RNA Silencing ALAS1 for Acute Intermittent Porphyria	27
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VIS649 (Sibeprenlimab), an APRIL-Neutralizing IgG2 Monoclonal Antibody, in Healthy Volunteers	27
Chronic Kidney Disease of Unknown Etiology in India: What Do We Know and Where We Need to Go	27
Endothelin Type A Receptor Antibodies Are Associated With Angiotensin II Type 1 Receptor Antibodies, Vascular Inflammation, and Decline in Renal Function in Pediatric Kidney Transplantation	27
Pre-dialysis Hyponatremia and Change in Serum Sodium Concentration During a Dialysis Session Are Significant Predictors of Mortality in Patients Undergoing Hemodialysis	26
Renal Recovery for Patients with ANCA-Associated Vasculitis and Low eGFR in the ADVOCATE Trial of Avacopan	26
Impact of Using Risk-Based Stratification on Referral of Patients With Chronic Kidney Disease From Primary Care to Specialist Care in the United Kingdom	26
Safety, Efficacy, and Relapse of Nirmatrelvir-Ritonavir in Kidney Transplant Recipients Infected With SARS-CoV-2	26
Elevated Neutrophil Gelatinase-Associated Lipocalin Is Associated With the Severity of Kidney Injury and Poor Prognosis of Patients With COVID-19	26
Predialysis Care Trajectories of Patients With ESKD Starting Dialysis in Emergency in France	26
COVID-19 Vaccine Hesitancy in Patients on Dialysis in Italy and France	25

Report of Three Cases of Minimal Change Disease Following the Second Dose of mRNA SARS-CoV-2 COVID-19 Vaccine	25
On Path to Informing Hierarchy of Eplet Mismatches as Determinants of Kidney Transplant Loss	25
An Evaluation of Commonly Used Surrogate Baseline Creatinine Values to Classify AKI During Acute Infection	25
Prevalence and Associated Factors of Chronic Kidney Disease among Relatives of Hemodialysis Patients in Saudi Arabia	25
Development and External Validation of a Machine Learning Model for Progression of CKD	25
A Narrative Review of Management Strategies for Common Symptoms in Advanced CKD	25
Letter regarding: “A Case of Gross Hematuria and IgA Nephropathy Flare-Up Following SARS-CoV-2 Vaccination”	24
The Rational Use of Complement Inhibitors in Kidney Diseases	24
Evaluation of Urinary Biomarkers of Proximal Tubular Injury, Inflammation, and Fibrosis in Patients With Albuminuric and Nonalbuminuric Diabetic Kidney Disease	24
Acute Kidney Injury Incidence, Recovery, and Long-term Kidney Outcomes Among Hospitalized Patients With COVID-19 and Influenza	24
Denosumab Recovers Aortic Arch Calcification During Long-Term Hemodialysis	24
POS-546 EFFICACY AND SAFETY OF IPTACOPAN IN IgA NEPHROPATHY: RESULTS OF A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED PHASE 2 STUDY AT 6 MONTHS	24
Long-Term Transplantation Outcomes in Patients With Primary Hyperoxaluria Type 1 Included in the European Hyperoxaluria Consortium (OxalEurope) Registry	24
Comparison of Vaccine Effectiveness Against the Omicron (B.1.1.529) Variant in Hemodialysis Patients	24
Variable Expressivity of HNF1B Nephropathy, From Renal Cysts and Diabetes to Medullary Sponge Kidney Through Tubulo-interstitial Kidney Disease	24
Prevalence, Characteristics, and Outcomes of Incidental IgA Glomerular Deposits in Donor Kidneys	24
Past, Present, and Future of Phosphate Management	24
Assessing the Accuracy of ChatGPT on Core Questions in Glomerular Disease	24
Early Administration of Anti–SARS-CoV-2 Monoclonal Antibodies Prevents Severe COVID-19 in Kidney Transplant Patients	24
A Novel Scoring System Based on Oxford Classification Indicating Steroid Therapy Use for IgA Nephropathy	23
Randomized Trial—PrEscription of intraDialytic exercise to improve quAlity of Life in Patients Receiving Hemodialysis	23
The Associations of Plasma Biomarkers of Inflammation With Histopathologic Lesions, Kidney Disease Progression, and Mortality—The Boston Kidney Biopsy Cohort Study	23
Atypical Hemolytic and Uremic Syndrome Triggered by Infection With SARS-CoV2	23
Incremental and Personalized Hemodialysis Start: A New Standard of Care	23
Hepatic Lactate Dehydrogenase A: An RNA Interference Target for the Treatment of All Known Types of Primary Hyperoxaluria	23
A Systematic Review of the Incidence of Arrhythmias in Hemodialysis Patients Undergoing Long-Term Monitoring With Implantable Loop Recorders	23
Understanding Mesangial Pathobiology in AL-Amyloidosis and Monoclonal Ig Light Chain Deposition Disease	23
Gender Disparities in Kidney Transplantation Referral Vary by Age and Race: A Multiregional Cohort Study in the Southeast United States	22
Low-Level Proteinuria in Systemic Lupus Erythematosus	22
Use of the Selective Cytopheretic Device in Critically Ill Children	22
Critical Illness and Systemic Inflammation Are Key Risk Factors of Severe Acute Kidney Injury in Patients With COVID-19	22
A Systematic Review and Meta-Analysis on Effects of Bicarbonate Therapy on Kidney Outcomes	22
Remdesivir in Patients With Estimated GFR <30 ml/min per 1.73 m2 or on Renal Replacement Therapy	22
Treatment of Iron Deficiency Anemia in CKD and End-Stage Kidney Disease	22
Use of Urine Electrolytes and Urine Osmolality in the Clinical Diagnosis of Fluid, Electrolytes, and Acid-Base Disorders	22
Incremental Versus Standard (Full-Dose) Peritoneal Dialysis	22
Impact of Deceased Donor Kidney Procurement Biopsy Technique on Histologic Accuracy	21
Cost-Effectiveness of Targeted Exome Analysis as a Diagnostic Test in Glomerular Diseases	21
Anti-PLA2R1 Antibodies as Prognostic Biomarker in Membranous Nephropathy	21
Efficacy and Safety of PCSK9 Inhibitors in Hypercholesterolemia Associated With Refractory Nephrotic Syndrome	21
Immune-Complex Glomerulonephritis After COVID-19 Infection	21
Hyperkalemia and its Association With Mortality, Cardiovascular Events, Hospitalizations, and Intensive Care Unit Admissions in a Population-Based Retrospective Cohort	21
The COVID-19 Pandemic Identifies Significant Global Inequities in Hemodialysis Care in Low and Lower-Middle Income Countries—An ISN/DOPPS Survey	21
Heterozygous Pathogenic COL4A3 and COL4A4 Variants (Autosomal Dominant Alport Syndrome) Are Common, and Not Typically Associated With End-Stage Kidney Failure, Hearing Loss, or Ocular Abnormalities	21
Fibroblast Growth Factor 23 and Mortality Among Prevalent Hemodialysis Patients in the Japan Dialysis Outcomes and Practice Patterns Study	21
Cardiac Biomarkers and Risk of Mortality in CKD (the CRIC Study)	21
Shared Decision-Making for a Dialysis Modality	20
Efficacy and Safety of Dapagliflozin in Children With Inherited Proteinuric Kidney Disease: A Pilot Study	20
The Role of Glomerular Epithelial Injury in Kidney Function Decline in Patients With Diabetic Kidney Disease in the TRIDENT Cohort	20
Cardiac Outcomes in Isolated Heart and Simultaneous Kidney and Heart Transplants in the United States	20
Why is Intradialytic Hypotension the Commonest Complication of Outpatient Dialysis Treatments?	20
Informing the Risk of Kidney Transplantation Versus Remaining on the Waitlist in the Coronavirus Disease 2019 Era	20
Analysis and Management of Rituximab Resistance in PLA2R1-Associated Membranous Nephropathy	20
Living Well With Kidney Disease and Effective Symptom Management: Consensus Conference Proceedings	20
Systematic Review of Risk factors and Incidence of Acute Kidney Injury Among Patients Treated with CAR-T Cell Therapies	20
Telemedicine for Outpatient Care of Kidney Transplant and CKD Patients	20
Clinicopathologic Features of Mitochondrial Nephropathy	19
Randomized Clinical Trial on the Long-Term Efficacy and Safety of Lumasiran in Patients With Primary Hyperoxaluria Type 1	19
Nephrotic Syndrome Following ChAdOx1 nCoV-19 Vaccine Against SARScoV-2	19
The Proximal Tubule Toxicity of Immunoglobulin Light Chains	19
Long-Term Outcomes of Children and Adolescents With Biopsy-Proven Childhood-Onset Lupus Nephritis	19
Concurrent Antiglomerular Basement Membrane Nephritis and Antineutrophil Cytoplasmic Autoantibody–Mediated Glomerulonephritis After Second Dose of SARS-CoV-2 mRNA Vaccination	19
A Newly Recognized Endemic Region of CKD of Undetermined Etiology (CKDu) in South India—“Tondaimandalam Nephropathy”	19
Acute Peritoneal Dialysis With Percutaneous Catheter Insertion for COVID-19–Associated Acute Kidney Injury in Intensive Care: Experience From a UK Tertiary Center	19
Sex-Specific Differences in Mortality and Incident Dialysis in the Chronic Kidney Disease Outcomes and Practice Patterns Study	19
The Global Impact of the COVID-19 Pandemic on In-Center Hemodialysis Services: An ISN-Dialysis Outcomes Practice Patterns Study Survey	19
Timing of COVID-19 Vaccine in the Setting of Anti-CD20 Therapy: A Primer for Nephrologists	18
Early Eculizumab Withdrawal in Patients With Atypical Hemolytic Uremic Syndrome in Native Kidneys Is Safe and Cost-Effective: Results of the CUREiHUS Study	18
Mortality Trends After Transfer From Peritoneal Dialysis to Hemodialysis	18
NELL1-Associated Membranous Glomerulopathy After Hematopoietic Stem Cell Transplantation	18
Clinicopathologic Features of Acute Kidney Injury Associated With CDK4/6 Inhibitors	18
Anticancer Drug-Induced Capillary Leak Syndrome	18
Avacopan as First-Line Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Steroid-Sparing Option	18
Nicotinamide Adenine Dinucleotide Biosynthetic Impairment and Urinary Metabolomic Alterations Observed in Hospitalized Adults With COVID-19–Related Acute Kidney Injury	18
Social Deprivation Is Associated With Lower Access to Pre-emptive Kidney Transplantation and More Urgent-Start Dialysis in the Pediatric Population	18
Assessment of Plasma Oxalate Concentration in Patients With CKD	18
Safety and Efficacy of GFB-887, a TRPC5 Channel Inhibitor, in Patients With Focal Segmental Glomerulosclerosis, Treatment-Resistant Minimal Change Disease, or Diabetic Nephropathy: TRACTION-2 Trial De	18
Acute Kidney Disease After Acute Decompensated Heart Failure	18
Targeting the Alternative Complement Pathway With Iptacopan to Treat IgA Nephropathy: Design and Rationale of the APPLAUSE-IgAN Study	18
Novel Treatments Paradigms: Membranous Nephropathy	18

Comprehensive Genetic Analysis Reveals Complexity of Monogenic Urinary Stone Disease	18
A Systematic Review of Renal Pathology in Chronic Kidney Disease of Uncertain Etiology	18
The Exostosin Immunohistochemical Status Differentiates Lupus Membranous Nephropathy Subsets With Different Outcomes	17
Blood Transfusion and Adverse Graft-related Events in Kidney Transplant Patients	17
Efficacy of Corticosteroids in Infection-Related Glomerulonephritis–A Randomized Controlled Trial	17
COVID-19 and Glomerular Diseases	17
Outcome and Determinants of Outcome of COVID-19 Infection Among Hemodialysis Patients: Findings From a National Dialysis Network Program in India	17
Principles of Virtual Crossmatch Testing for Kidney Transplantation	17
Genetic Background and Clinicopathologic Features of Adult-onset Nephronophthisis	17
Last Nucleotide Substitutions of COL4A5 Exons Cause Aberrant Splicing	17
Establishing a Case for Anti-complement Therapy in Membranous Nephropathy	16
Long-Term Outcomes of C3 Glomerulopathy and Immune-Complex Membranoproliferative Glomerulonephritis in Children	16
Recalibration of the Renal Angina Index for Pediatric Septic Shock	16
Tixagevimab and Cilgavimab (Evusheld) in Rituximab-treated Antineutrophil Cytoplasmic Antibody Vasculitis Patients	16
Prediction of Incident Heart Failure in CKD: The CRIC Study	16
Survey of Telemedicine by Pediatric Nephrologists During the COVID-19 Pandemic	16
Increasing Discards as an Unintended Consequence of Recent Changes in United States Kidney Allocation Policy	16
Image Analysis Pipeline for Renal Allograft Evaluation and Fibrosis Quantification	16
Glomerular Classification Using Convolutional Neural Networks Based on Defined Annotation Criteria and Concordance Evaluation Among Clinicians	16
COVID-19−Associated Decline in the Size of the End-Stage Kidney Disease Population in the United States	16
Two Cases of Double-Positive Antineutrophil Cytoplasmic Autoantibody and Antiglomerular Basement Membrane Disease After BBV152/Covaxin Vaccination	16
Endothelial Endothelin Receptor A Expression Is Associated With Podocyte Injury and Oxidative Stress in Patients With Focal Segmental Glomerulosclerosis	16
Glomerular Complement Factor H–Related Protein 5 is Associated with Histologic Injury in Immunoglobulin A Nephropathy	16
Evaluation of Kidney Histological Images Using Unsupervised Deep Learning	16
Clonal Hematopoiesis of Indeterminate Potential and Diabetic Kidney Disease: A Nested Case-Control Study	16
Patient-Reported Gastrointestinal Symptoms and the Association With Quality of Life Following Kidney Transplantation	16
Performance and Determinants of Serum Creatinine and Cystatin C–Based GFR Estimating Equations in South Asians	16
Supportive Management of IgA Nephropathy With Renin-Angiotensin Blockade, the AIIMS Primary IgA Nephropathy Cohort (APPROACH) Study	16
Stress Related Disorders and the Risk of Kidney Disease	16
Kidney Thrombotic Microangiopathy After COVID-19 Associated With C3 Gene Mutation	16
Patients’ Perspectives on Access to Dialysis and Kidney Transplantation in Rural Communities in Australia	16
Early Identification of CKD—A Scoping Review of the Global Populations	16
Vancomycin-Associated Tubular Casts and Vancomycin Nephrotoxicity	16
Genetic Variants of APOL1 Are Major Determinants of Kidney Failure in People of African Ancestry With HIV	15
A New Approach to Recognize Neonatal Impaired Kidney Function	15
Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy	15
Cytokines and Immune Cell Phenotype in Acute Kidney Injury Associated With Immune Checkpoint Inhibitors	15
Gender Disparities in Access to Kidney Transplant: Inequities in the Inequity	15
Vascular Calcification Slows But Does Not Regress After Kidney Transplantation	15
Biomarkers of Kidney Tubule Disease and Risk of End-Stage Kidney Disease in Persons With Diabetes and CKD	15
Proteinuria Increases the PLASMIC and French Scores Performance to Predict Thrombotic Thrombocytopenic Purpura in Patients With Thrombotic Microangiopathy Syndrome	15
Tolvaptan in ADPKD Patients With Very Low Kidney Function	15
Molecular Mechanisms of Rhabdomyolysis-Induced Kidney Injury: From Bench to Bedside	15
Overview of Antibiotic-Induced Nephrotoxicity	15
Systematic Review of Genotype-Phenotype Correlations in Frasier Syndrome	15
Pilot Randomized Controlled Trial of a Standard Versus a Modified Low-Phosphorus Diet in Hemodialysis Patients	15
Prescribing SGLT2 Inhibitors in Patients With CKD: Expanding Indications and Practical Considerations	15
Narrative Review of the Relationship Between CKD and Diabetic Foot Ulcer	15
Dose-Response of Tenapanor in Patients With Hyperphosphatemia Undergoing Hemodialysis in Japan—A Phase 2 Randomized Trial	15
A Narrative Review of Dietary Approaches for Kidney Transplant Patients	15
PodoCount: A Robust, Fully Automated, Whole-Slide Podocyte Quantification Tool	14
Association of Local Unit Sampling and Microbiology Laboratory Culture Practices With the Ability to Identify Causative Pathogens in Peritoneal Dialysis-Associated Peritonitis in Thailand	14
Autosomal Recessive Renal Tubular Dysgenesis Caused by a Founder Mutation of Angiotensinogen	14
A Pilot Study to Predict Risk of IgA Nephropathy Progression Based on miR-204 Expression	14
Risk of Atypical HUS Among Family Members of Patients Carrying Complement Regulatory Gene Abnormality	14
Effect of Vancomycin on the Gut Microbiome and Plasma Concentrations of Gut-Derived Uremic Solutes	14
Impact of Pregnancy on GFR Decline and Kidney Histology in Kidney Transplant Recipients	14
Rising Incidence of End-Stage Kidney Disease and Poorer Access to Kidney Transplant Among Australian Aboriginal and Torres Strait Islander Children and Young Adults	14
The Effect of Age on Performance of the Kidney Failure Risk Equation in Advanced CKD	14
Underrepresentation of Women in Recent Landmark Kidney Trials: The Gender Gap Prevails	14
Unmet Needs of CKD in Latin America: A Review from Expert Virtual Working Group	14
A National Registry Study of Patient and Renal Survival in Adult Nephrotic Syndrome	14
Real-Time Acute Kidney Injury Risk Stratification–Biomarker Directed Fluid Management Improves Outcomes in Critically Ill Children and Young Adults	14
The Independent Effects of Procurement Biopsy Findings on 10-Year Outcomes of Extended Criteria Donor Kidney Transplants	14
Diabetes Prevalence, Treatment, Control, and Outcomes Among Hemodialysis Patients in the Gulf Cooperation Council Countries	14
The variety of genetic defects explains the phenotypic heterogeneity of Familial Hyperkalemic Hypertension	14
Occurrence of De novo Donor-Specific Antibodies After COVID-19 in Kidney Transplant Recipients Is Low Despite Immunosuppression Modulation	14
Iron Deficiency in CKD Without Concomitant Anemia	14
IgA Nephropathy Patient Baseline Characteristics in the Sparsentan PROTECT Study	14
Role of C5 inhibition in Idiopathic Inflammatory Myopathies and Scleroderma Renal Crisis–Induced Thrombotic Microangiopathies	14
One-Year Outcomes of the Multi-Center StudY to Transplant Hepatitis C-InfeCted kidneys (MYTHIC) Trial	13
POS-830 NEFECON FOR THE TREATMENT OF IgA NEPHROPATHY IN PATIENTS AT RISK OF PROGRESSING TO END-STAGE RENAL DISEASE: THE NEFIGARD PHASE 3 TRIAL RESULTS	13
A Cost-Effective Analysis of the CYCLE-HD Randomized Controlled Trial	13
Quantitative Blood Oxygenation Level Dependent Magnetic Resonance Imaging for Estimating Intra-renal Oxygen Availability Demonstrates Kidneys Are Hypoxemic in Human CKD	13
Minimal Change Disease Is Associated With Endothelial Glycocalyx Degradation and Endothelial Activation	13
Neutralizing Antibody Responses After SARS-CoV-2 Infection in End-Stage Kidney Disease and Protection Against Reinfection	13
Functional and Genetic Landscape of Complement Dysregulation Along the Spectrum of Thrombotic Microangiopathy and its Potential Implications on Clinical Outcomes	13
Integrating CKD Into US Primary Care: Bridging the Knowledge and Implementation Gaps	13
Estimating Baseline Serum Creatinine for Assessing Acute Kidney Injury: Not a One Size Fits All Approach	13
Urinary CD80 Discriminates Among Glomerular Disease Types and Reflects Disease Activity	13
Identifying Information Needs of Patients With IgA Nephropathy Using an Innovative Social Media–stepped Analytical Approach	13
A Systematic Review of Clinical Characteristics and Histologic Descriptions of Acute Tubular Injury	13
Diagnostic Approach to Glomerulonephritis With Fibrillar IgG Deposits and Light Chain Restriction	13
Factors Influencing Long-Term Patient and Allograft Outcomes in Elderly Kidney Transplant Recipients	13
Kidney Involvement in Patients With Chronic Myelomonocytic Leukemia or BCR-ABL–Negative Myeloproliferative Neoplasms	13
N-Acetylcysteine Interference With Creatinine Measurement: An In Vitro Analysis	13
IgA Nephropathy Is the Most Common Underlying Disease in Patients With Anticoagulant-Related Nephropathy	13
The Adaptive Renal Response for Volume Homeostasis During 2 Weeks of Dapagliflozin Treatment in People With Type 2 Diabetes and Preserved Renal Function on a Sodium-Controlled Diet	13
CKD After 225Ac-PSMA617 Therapy in Patients With Metastatic Prostate Cancer	13
Enhanced MCP-1 Release in Early Autosomal Dominant Polycystic Kidney Disease	13
Daratumumab in Patients With Bortezomib-Refractory Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits	13
Primary Podocytopathies After COVID-19 Vaccination	13
Hypocomplementemia at Diagnosis of Pauci-immune Glomerulonephritis Is Associated With Advanced Histopathological Activity Index and High Probability of Treatment Resistance	12
Antibody-Guided Therapy in Phospholipase A2 Receptor-Associated Membranous Nephropathy	12
Incidence, Risk Factors, and Outcomes of Kidney Transplant Recipients With BK Polyomavirus-Associated Nephropathy	12